Biotech China 2014

Leukemia: National Institutes of Health

Total Score People Score Events Score
29 26 14
Date Event Presentation Speakers
May 31, 2013 ASCO Annual Meeting 2013 Special Session Worta McCaskill-Stevens
April 6, 2013 AACR Annual Meetings BRAF Pathway Inhibitors in Melanoma: Where Do We Go from Here? Chairperson: Richard M. Marais, Paterson Institute for Cancer Research, Manchester, United Kingdom Deborah Morrison
The MICR Scientific Symposium: Why Are Aggressive Forms of Cancer More Common Among Certain Racial/Ethnic Groups? Co-Chairpersons: Christopher I. Li, Fred Hutchinson Cancer Research Center, Seattle, WA, and A. William Blackstock, Wake Forest University School of Medicine, Winston-Salem, NC Curtis C. Harris
Lymphoid Malignancies Co-Chairpersons: Peter J. Campbell, Wellcome Trust Sanger Institute, Cambridge, United Kingdom, and Louis M. Staudt, National Cancer Institute, Bethesda, MD Louis M. Staudt
Novel Therapeutic Concepts with Kinases, Immuno-, and Radiotherapy Chairperson: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY W. Marston Linehan
Predictive Modeling of Cancer Treatment in Single Patients (N of 1) Moderator: Charles L. Sawyers, Memorial Sloan-Kettering Cancer Center, New York, NY James H. DOROSHOW
Rational Combination Therapies in Cancer Chairperson: Gordon B. Mills, The University of Texas MD Anderson Cancer Center, Houston, TX Louis M. Staudt
Immune Reconstitution Following Lymphodepleting Cancer Therapy: Does It Matter? Crystal L. Mackall, National Cancer Institute, Bethesda, MD Crystal Mackall
December 8, 2012 54th American Society of Haematology Annual Meeting and Exposition Career-Development Lunch Sessions Cynthia E. Dunbar
Trainee Simultaneous Didactic Sessions Cynthia E. Dunbar
August 24, 2012 21st Annual Short Course on Experimental Models of Human Cancer Systems Genetics of Metastasis Susceptibility Kent W. Hunter
January 8, 2012 Chemokines and Leukocyte Trafficking in Homeostasis and Inflammation Short Talk | Non-Random Layered Organization of Effector Cells in the Lymph Node Allows for Optimal Pathogen Defense Wolfgang K. Kastenmuller
December 13, 2011 New Horizons in Cancer Research: Biology to Prevention to Therapy Day in Review Curtis C. Harris
Inflammation and cancer: Interweaving microRNA, innate immune, and p53 networks Curtis C. Harris
Concurrent Session 4 | Cancer Genetics Curtis C. Harris
July 30, 2011 MD Anderson Physicians Network Symposium Changing Paradigms in Cancer Treatment and Patient Management When Should We Use MRI in Breast Cancer Follow-Up? Wei Yang
Breast Cancer Screening and the Impact of Breast Density Wei Yang
April 12, 2011 New Insights into Normal versus Dysregulated B Cell Function (D6) Converging on the Achilles Heel of Lymphoma through Functional and Structural Genomics Louis M. Staudt
Seq-ing AID in B Cell Tumor Development R Casellas
Immunopathogenesis of B Cells in HIV Infection Susan Moir
February 17, 2011 15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma Comment Wyndham H. Wilson
Toward Optimal Initial Management of Mantle Cell Lymphoma Wyndham H. Wilson
Lymphoma Wyndham H. Wilson
November 6, 2009 Translating Scientific Advances Into Clinical Care for Cancer Genitourinary Cancer W. Marston Linehan
August 18, 2009 Inaugural Novel Vaccines: Adjuvants & Delivery Systems Adjuvant Properties of CpG Oligonucleotides Dennis M. Klinman
May 30, 2008 ASCO Annual'08 Meeting breast cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
cancer genetics-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
clinical trials-- The End of P Values? Why Alternative Methods to Making Inferences May Be Superior Steven Hirschfeld
developmental therapeutics-- DNA Repair Modulators Yves Pommier
genitourinary cancer-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
lymphoma and plasma cell disorders-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
patient and survivor care-- Second Primary Cancers: New Population-Based Results and an Overview of Survivors at Risk Lois B. Travis
pediatric cancer-- Neurofibromatosis Type 1: The Development and Treatment of Neural Tumors Brigitte C. Widemann
special sessions-- Opening Ceremony with Presidential Address, NCI Director’s Address, The ASCO Cancer Foundation Donor Appreciation Awards, and Karnofsky Memorial Award Lecture John E. Niederhuber
tumor biology-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- Molecular and Pharmacokinetic Aspects of Brain Metastases (M04) Patricia Steeg
meet the professor sessions-- How to Interpret and Communicate the Risks of Therapy-Related Complications: Demystifying Epidemiologic Research (M08) Lois B. Travis
October 11, 2007 Sixth International Colorectal Cancer Congress Inhibition of Hepatocyte Growth Factor and the c-Met Receptor John J. Wright
PI3K Inhibitors John J. Wright
July 21, 2007 Hematopoietic Malignancies A cell-cycle independent function of tumor suppressor Ink4b in regulation of lineage choice” Linda Wolff
The ability of CBFβ-SMMHC to repress RUNX1 does not correlate with its ability to induce leukemia Paul Liu
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma Christina Annunziata
DNA damage and oncogenic stress: barriers to chromosomal translocations Andre Nussenzweig
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.